$AMLN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMYLIN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMYLIN PHARMACEUTICALS INC. Get notifications about new insider transactions in AMYLIN PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2009 | AMLN | AMYLIN PHARMACEUTI ... | Denner Alexander J | Director | Option Exercise | A | 11.26 | 30,000 | 337,800 | 30,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 11.68 | 20,000 | 233,600 | 20,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 11.68 | 20,000 | 233,600 | 20,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 11.68 | 20,000 | 233,600 | 20,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 11.68 | 20,000 | 233,600 | 20,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 11.68 | 20,000 | 233,600 | 20,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 11.68 | 20,000 | 233,600 | 20,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | Costa Paulo F | Director | Option Exercise | A | 11.26 | 30,000 | 337,800 | 30,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | CLARK PAUL N | Director | Option Exercise | A | 11.26 | 30,000 | 337,800 | 30,000 | |
Jun 10 2009 | AMLN | AMYLIN PHARMACEUTI ... | BEHRENS M KATHLEEN | Director | Option Exercise | A | 11.26 | 30,000 | 337,800 | 30,000 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 4,404 | 0 | 15,695 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 3,549 | 0 | 10,622 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 1,512 | 0 | 10,458 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Option Exercise | A | 0.00 | 1,512 | 0 | 5,530 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Gift | G | 0.00 | 8,565 | 0 | 139,450 | 148 K to 139.5 K (-5.79 %) |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 2,208 | 0 | 6,771 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 3,812 | 0 | 11,971 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 0.00 | 1,709 | 0 | 6,681 | |
Apr 07 2009 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 1,315 | 0 | 6,276 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | A | 9.02 | 13,750 | 124,025 | 23,750 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | A | 9.02 | 10,000 | 90,200 | 10,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | A | 9.02 | 6,250 | 56,375 | 6,250 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Sales and Marke ... | Option Exercise | A | 9.02 | 30,000 | 270,600 | 30,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Option Exercise | A | 9.02 | 44,403 | 400,515 | 89,403 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Option Exercise | A | 9.02 | 45,000 | 405,900 | 45,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Option Exercise | A | 9.02 | 5,597 | 50,485 | 5,597 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Informat ... | Option Exercise | A | 9.02 | 50,817 | 458,369 | 80,817 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Informat ... | Option Exercise | A | 9.02 | 30,000 | 270,600 | 30,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Informat ... | Option Exercise | A | 9.02 | 4,183 | 37,731 | 4,183 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Informat ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP Legal & Corp ... | Option Exercise | A | 9.02 | 49,954 | 450,585 | 79,954 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP Legal & Corp ... | Option Exercise | A | 9.02 | 30,000 | 270,600 | 30,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP Legal & Corp ... | Option Exercise | A | 9.02 | 5,046 | 45,515 | 5,046 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP Legal & Corp ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 9.02 | 42,186 | 380,518 | 92,186 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 9.02 | 50,000 | 451,000 | 50,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | A | 9.02 | 2,814 | 25,382 | 2,814 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP Corporate Dev ... | Option Exercise | A | 9.02 | 51,561 | 465,080 | 81,561 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP Corporate Dev ... | Option Exercise | A | 9.02 | 30,000 | 270,600 | 30,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP Corporate Dev ... | Option Exercise | A | 9.02 | 3,439 | 31,020 | 3,439 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP Corporate Dev ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Option Exercise | A | 9.02 | 56,248 | 507,357 | 86,248 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Option Exercise | A | 9.02 | 30,000 | 270,600 | 30,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Option Exercise | A | 9.02 | 3,752 | 33,843 | 3,752 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | A | 9.02 | 10,313 | 93,023 | 20,313 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | A | 9.02 | 10,000 | 90,200 | 10,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Option Exercise | A | 9.02 | 4,687 | 42,277 | 4,687 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Grant | A | 0.00 | 554 | 0 | 755 | 201 to 755 (+275.62 %) |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | A | 9.02 | 188,912 | 1,703,986 | 388,912 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | A | 9.02 | 200,000 | 1,804,000 | 200,000 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Option Exercise | A | 9.02 | 11,088 | 100,014 | 11,088 | |
Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Grant | A | 0.00 | 2,550 | 0 | 3,455 | 905 to 3.5 K (+281.77 %) |
Feb 27 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Option Exercise | M | 0.78 | 16,344 | 12,765 | 0 | |
Feb 27 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Buy | M | 0.78 | 16,344 | 12,765 | 143,265 | 126.9 K to 143.3 K (+12.88 %) |
Feb 11 2009 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Sales and Marke ... | Option Exercise | A | 13.05 | 34,514 | 450,408 | 34,514 | |
Feb 11 2009 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Sales and Marke ... | Option Exercise | A | 13.05 | 25,486 | 332,592 | 25,486 | |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Grant | A | 11.80 | 127 | 1,499 | 824,414 | 824.3 K to 824.4 K (+0.02 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Grant | A | 11.80 | 585 | 6,903 | 13,197 | 12.6 K to 13.2 K (+4.64 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | EBERHARD CRAIG A | VP Sales | Grant | A | 11.80 | 585 | 6,903 | 24,464 | 23.9 K to 24.5 K (+2.45 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | FOLETTA MARK G | Sr VP Finance & CFO | Grant | A | 11.80 | 585 | 6,903 | 24,839 | 24.3 K to 24.8 K (+2.41 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | KOLTERMAN ORVILLE G | Sr VP Clinical and ... | Grant | A | 11.80 | 585 | 6,903 | 126,921 | 126.3 K to 126.9 K (+0.46 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | Lloyd Marcea Bland | Sr VP Legal & Corp ... | Grant | A | 11.80 | 585 | 6,903 | 1,918 | 1.3 K to 1.9 K (+43.89 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | MARCHETTI ROGER | Sr VP HR & Informat ... | Grant | A | 11.80 | 585 | 6,903 | 4,899 | 4.3 K to 4.9 K (+13.56 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | Marshall Paul | VP Operations | Grant | A | 11.80 | 585 | 6,903 | 767 | 182 to 767 (+321.43 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Grant | A | 11.80 | 585 | 6,903 | 25,113 | 24.5 K to 25.1 K (+2.39 %) |
Feb 05 2009 | AMLN | AMYLIN PHARMACEUTI ... | Gergen Mark J | Sr VP Corporate Dev ... | Grant | A | 11.80 | 585 | 6,903 | 4,506 | 3.9 K to 4.5 K (+14.92 %) |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 1,663 | 0 | 11,291 | |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 0.00 | 1,610 | 0 | 7,073 | |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 1,234 | 0 | 8,946 | |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Option Exercise | A | 0.00 | 1,234 | 0 | 4,018 | |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 901 | 0 | 4,563 | |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 1,824 | 0 | 8,159 | |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 0.00 | 1,395 | 0 | 4,972 | |
Jan 15 2009 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 1,288 | 0 | 4,961 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 0.00 | 850 | 0 | 3,577 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Option Exercise | A | 0.00 | 752 | 0 | 2,784 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 1,013 | 0 | 9,628 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 1,111 | 0 | 6,335 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 752 | 0 | 7,712 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 785 | 0 | 3,662 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 752 | 0 | 7,039 | |
Oct 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 785 | 0 | 3,673 | |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.77 | 1,000,000 | 21,770,000 | 17,200,000 | 18.2 M to 17.2 M (-5.49 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.58 | 180,321 | 3,891,327 | 18,200,000 | 18.4 M to 18.2 M (-0.98 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.23 | 3,904,541 | 82,893,405 | 18,380,321 | 22.3 M to 18.4 M (-17.52 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 21.05 | 691,700 | 14,560,285 | 22,284,862 | 23 M to 22.3 M (-3.01 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 20.28 | 50,000 | 1,014,000 | 22,976,562 | 23 M to 23 M (-0.22 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 20.07 | 200,000 | 4,014,000 | 23,026,562 | 23.2 M to 23 M (-0.86 %) |
Aug 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Option Exercise | M | 16.54 | 100 | 1,654 | 28,649 | |
Aug 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Sell | S | 35.00 | 100 | 3,500 | 24,427 | 24.5 K to 24.4 K (-0.41 %) |
Aug 20 2008 | AMLN | AMYLIN PHARMACEUTI ... | ROWLAND LLOYD A | VP Governance Compl ... | Buy | M | 16.54 | 100 | 1,654 | 24,527 | 24.4 K to 24.5 K (+0.41 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 21.77 | 695,705 | 15,145,498 | 12,116,463 | 12.8 M to 12.1 M (-5.43 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 21.58 | 125,450 | 2,707,211 | 12,812,168 | 12.9 M to 12.8 M (-0.97 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 21.23 | 2,716,411 | 57,669,406 | 12,937,618 | 15.7 M to 12.9 M (-17.35 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 21.05 | 481,219 | 10,129,660 | 15,654,029 | 16.1 M to 15.7 M (-2.98 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 20.28 | 34,786 | 705,460 | 16,135,248 | 16.2 M to 16.1 M (-0.22 %) |
Aug 29 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Sell | S | 20.07 | 139,142 | 2,792,580 | 16,170,034 | 16.3 M to 16.2 M (-0.85 %) |
Jul 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 2,000 | 0 | 854,287 | 856.3 K to 854.3 K (-0.23 %) |
Aug 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 32.07 | 30,000 | 962,184 | 824,287 | 854.3 K to 824.3 K (-3.51 %) |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 0.00 | 739 | 0 | 8,615 | |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 0.00 | 548 | 0 | 6,287 | |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 0.00 | 548 | 0 | 6,960 | |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Option Exercise | A | 0.00 | 548 | 0 | 2,032 | |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 0.00 | 572 | 0 | 2,877 | |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 0.00 | 810 | 0 | 5,224 | |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 0.00 | 619 | 0 | 2,727 | |
Jul 07 2008 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 0.00 | 572 | 0 | 2,888 | |
Jun 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.93 | 92,673 | 2,773,703 | 16,309,176 | 16.2 M to 16.3 M (+0.57 %) |
Jun 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.91 | 18,534 | 554,352 | 16,216,503 | 16.2 M to 16.2 M (+0.11 %) |
Jun 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.93 | 125,000 | 3,741,250 | 23,226,562 | 23.1 M to 23.2 M (+0.54 %) |
Jun 06 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.91 | 25,000 | 747,750 | 23,101,562 | 23.1 M to 23.1 M (+0.11 %) |
Jun 03 2008 | AMLN | AMYLIN PHARMACEUTI ... | SULLIVAN JOSEPH P | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
Jun 02 2008 | AMLN | AMYLIN PHARMACEUTI ... | ADAMS ADRIAN | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | WILSON JAMES N | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | SKYLER JAY S | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | GREENE HOWARD E JR | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | GRAHAM GINGER L | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | GAVIN JAMES R III | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTHAM KARIN | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | BECK TERESA | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | ALTMAN STEVEN R | Director | Option Exercise | A | 31.77 | 12,000 | 381,240 | 12,000 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | A | 30.98 | 16,773 | 519,628 | 16,773 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Option Exercise | A | 30.98 | 3,227 | 99,972 | 3,227 | |
May 30 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 32.00 | 10,000 | 320,000 | 856,287 | 866.3 K to 856.3 K (-1.15 %) |
May 19 2008 | AMLN | AMYLIN PHARMACEUTI ... | COOK JOSEPH C JR | Director | Sell | S | 32.00 | 30,000 | 960,090 | 866,287 | 896.3 K to 866.3 K (-3.35 %) |
May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.91 | 27,100 | 756,361 | 23,076,562 | 23 M to 23.1 M (+0.12 %) |
May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.91 | 193,406 | 5,397,961 | 23,049,462 | 22.9 M to 23 M (+0.85 %) |
May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.88 | 29,494 | 822,293 | 22,856,056 | 22.8 M to 22.9 M (+0.13 %) |
May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 27.91 | 18,061 | 504,083 | 16,197,969 | 16.2 M to 16.2 M (+0.11 %) |
May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 27.91 | 128,901 | 3,597,627 | 16,179,908 | 16.1 M to 16.2 M (+0.80 %) |
May 08 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 27.88 | 19,657 | 548,037 | 16,051,007 | 16 M to 16.1 M (+0.12 %) |
May 01 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 27.72 | 356,652 | 9,886,393 | 16,031,350 | 15.7 M to 16 M (+2.28 %) |
May 01 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 27.72 | 356,652 | 9,886,393 | 22,826,562 | 22.5 M to 22.8 M (+1.59 %) |
Apr 22 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.55 | 24,100 | 712,155 | 22,469,910 | 22.4 M to 22.5 M (+0.11 %) |
Apr 22 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 28.52 | 869,900 | 24,809,548 | 22,445,810 | 21.6 M to 22.4 M (+4.03 %) |
Apr 22 2008 | AMLN | AMYLIN PHARMACEUTI ... | BRADBURY DANIEL | President & Chief E ... | Gift | G | 0.00 | 177 | 0 | 44,402 | 44.6 K to 44.4 K (-0.40 %) |
Apr 22 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 29.55 | 24,100 | 712,155 | 15,674,698 | 15.7 M to 15.7 M (+0.15 %) |
Apr 22 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 28.52 | 869,900 | 24,809,548 | 15,650,598 | 14.8 M to 15.7 M (+5.89 %) |
Apr 17 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.35 | 50,000 | 1,517,500 | 21,575,901 | 21.5 M to 21.6 M (+0.23 %) |
Apr 17 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 30.78 | 19,471 | 599,317 | 21,525,901 | 21.5 M to 21.5 M (+0.09 %) |
Apr 17 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.35 | 50,000 | 1,517,500 | 14,780,698 | 14.7 M to 14.8 M (+0.34 %) |
Apr 17 2008 | AMLN | AMYLIN PHARMACEUTI ... | BLACK BEAR OFFSHORE MASTER FUN ... | 10% Owner | Buy | P | 30.78 | 19,471 | 599,317 | 14,730,698 | 14.7 M to 14.7 M (+0.13 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.30 | 27,389 | 802,498 | 21,506,439 | 21.5 M to 21.5 M (+0.13 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.24 | 1,300 | 38,012 | 21,479,050 | 21.5 M to 21.5 M (+0.01 %) |
Apr 15 2008 | AMLN | AMYLIN PHARMACEUTI ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 29.47 | 66,913 | 1,971,926 | 21,477,750 | 21.4 M to 21.5 M (+0.31 %) |